Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Tanioka, M; Fan, C; Carey, LA; Hyslop, T; Pitcher, BN; Parker, JA; Hoadley, KA; Henry, NL; Tolaney, S; Dang, C; Krop, IE; Harris, L; Berry, DA; Mardis, E; Perou, CM; Winer, EP; Hudis, CA

Published Date

  • February 15, 2017

Published In

  • General Session Abstracts

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.sabcs16-s3-05

Conference Name

  • Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas